CVRx, Inc. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CVRx, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $450.00K, a 25.00% increase year-over-year.
- CVRx, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-12-31 was $393.00K, a 1.01% decline year-over-year.
- CVRx, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $0.00.
- CVRx, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-06-30 was $360.00K, a 11.33% decline year-over-year.
- CVRx, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $753.00K, a 6.23% decline from fiscal 2024.
- CVRx, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $803.00K, a 14.12% decline from fiscal 2023.
- CVRx, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $935.00K, a 59.28% increase from fiscal 2022.
- CVRx, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $587.00K.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $450.00K 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $393.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $753.00K 10-K · filed 2026-02-13 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | |
| 2025-06-30 | $360.00K 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $397.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $803.00K 10-K · filed 2026-02-13 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | |
| 2024-06-30 | $406.00K 10-Q · filed 2025-08-05 | |
| 2023-12-31 | $483.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $935.00K 10-K · filed 2025-02-18 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | |
| 2023-06-30 | $452.00K 10-Q · filed 2024-08-02 | |
| 2022-12-31 | $292.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $587.00K 10-K · filed 2024-02-09 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | |
| 2022-06-30 | $295.00K 10-Q · filed 2023-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |